Open AccessCD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
Author(s) -
Vicki Plaks,
John M. Rossi,
Justin Chou,
Linghua Wang,
Soumya Poddar,
Guangchun Han,
Zixing Wang,
Shao-Qing Kuang,
Fuliang Chu,
R. Eric Davis,
Francisco Vega,
Zahid Bashir,
Caron A. Jacobson,
Frederick L. Locke,
Patrick M. Reagan,
Scott J. Rodig,
Lazaros J. Lekakis,
Ian W. Flinn,
David B. Miklos,
Adrian Bot,
Sattva S. Neelapu
Publication year - 2021
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2021010930
Subject(s) - evasion (ethics) , cd19 , b cell lymphoma , lymphoma , b cell , cancer research , medicine , immunology , virology , antigen , antibody , immune system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom